An Endocardial Pathway Involving Tbx5, Gata4, and Nos3 Required for Atrial Septum Formation

Total Page:16

File Type:pdf, Size:1020Kb

An Endocardial Pathway Involving Tbx5, Gata4, and Nos3 Required for Atrial Septum Formation An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation Mathieu Nadeaua,b,1, Romain O. Georgesa,b,1, Brigitte Laforesta,b, Abir Yamaka,c, Chantal Lefebvrea,b, Janie Beauregarda,c, Pierre Paradisa,2, Benoit G. Bruneaud, Gregor Andelfingera,e, and Mona Nemera,c,3 aResearch Unit in Cardiac Growth and Differentiation and bMolecular Biology Program, Université de Montréal, Montréal, QC, Canada H3C 3J7; cDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada K1N 6N5; dGladstone Institute of Cardiovascular Disease, Department of Pediatrics, University of California, San Francisco, CA 94158; and eDepartment of Cardiovascular Genetics, Hôpital Ste-Justine, Montréal, QC, Canada H3T 1C5 Edited* by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved October 5, 2010 (received for review January 5, 2010) In humans, septal defects are among the most prevalent congen- thelial gene expression and their knockdown in fish disrupted ital heart diseases, but their cellular and molecular origins are not vascular development (15). Others like the basic helix-loop-helix fully understood. We report that transcription factor Tbx5 is pres- transcription factor SCL (16) or Tbx20 (17) and Twist1 (18) are ent in a subpopulation of endocardial cells and that its deletion involved in early migration or proliferation of endocardial pro- therein results in fully penetrant, dose-dependent atrial septal genitors. Transcription factors associated with later stages of defects in mice. Increased apoptosis of endocardial cells lacking endocardial cell differentiation include Sox9 (19), Gata5 (20), Tbx5, as well as neighboring TBX5-positive myocardial cells of and NFATc (8, 21, 22). Last, GATA4 is expressed in early en- the atrial septum through activation of endocardial NOS (Nos3), docardial progenitors and persists therein throughout de- is the underlying mechanism of disease. Compound Tbx5 and Nos3 velopment (20, 23). The exact role of Gata4 in the endocardium is not fully understood but is thought to involve proliferation and haploinsufficiency in mice worsens the cardiac phenotype. The remodeling of the endocardial cushion (24). In this study, we data identify a pathway for endocardial cell survival and unravel Tbx5 fi Nos3 show that the transcription factor Tbx5, a member of the Tbox a cell-autonomous role for therein. The nding that , family of important developmental regulators, is expressed in a gene regulated by many congenital heart disease risk factors endocardial cells destined to form the atrial septum, where it Tbx5 including stress and diabetes, interacts genetically with pro- plays a cell-autonomous role in endocardial cell survival, thus vides a molecular framework to understand gene–environment identifying a regulatory pathway in endocardial growth and dif- interaction in the setting of human birth defects. ferentiation. In human, TBX5 mutations are linked to Holt– Oram syndrome, an autosomal-dominant disorder characterized heart development | Holt–Oram syndrome by upper-limb defects and a large spectrum of cardiac malfor- mations ranging from simple arrhythmia to complex structural n humans, the incidence of congenital heart disease (CHD) is malformations (25, 26). Conduction defects are thought to be Inow estimated to be nearly 5% of live births (1), and CHD is a consequence of Cx40 dysregulation. ASDs are the most com- fi mon cardiac malformations found in patients with Holt–Oram the major noninfectious cause of death in infants within the rst +/− year of life. Moreover, undiagnosed less severe defects increase syndrome (27) and in Tbx5 mice (28), but the cellular origin the risks of morbidity and premature mortality and constitute of the defects remains unknown. We now show that endocardial- fi risk factors for stroke, ischemic heart disease, and sudden death speci c mutation of Tbx5 causes dose-dependent ASDs and that (2). Secundum atrial septal defect (ASD) is the third most endocardial Tbx5 interacts genetically with Gata4 and endocar- common congenital heart malformation (3) and occurs as an dial NOS (Nos3) to regulate cell survival and atrial septum for- isolated defect or as a feature of more complex syndromes (4). A mation. The data provide a mechanism to explain synergy complex multifactorial inheritance model involving alterations in between a transcription factor and an enzyme in CHD. multiple genes and interactions with environment factors has Results been suggested to account for the lower penetrance and variable expressivity of familial ASDs (5). Heart development requires Loss of Tbx5 from the Endocardium Leads to CHD. To better identify differentiation, proliferation and cell–cell communication be- the cellular distribution of TBX5 within the heart, we performed tween two cell layers composed of myocardial and endocardial high-resolution immunohistochemical analysis of TBX5 protein in cells. Significant progress was accomplished in the past decade in the developing heart. Labeling with two different TBX5-specific identifying the molecules and mechanisms involved in myocar- antibodies revealed strong nuclear labeling in atrial and left ven- dial cell differentiation (reviewed in refs. 6, 7). Several key reg- tricular myocytes, consistent with previous reports on the distri- ulators of myocardial patterning and chamber specification have bution of Tbx5 transcripts (27, 28). In addition, labeling was found been identified. They include transcription factors GATA4, in cells of the endocardial cushions and in endocardial cells lining NKX2.5, and TBX5, mutations of which have been associated the atrial septal walls starting at approximately embryonic day with human ASDs (4). In contrast, molecular pathways involved in differentiation of the endocardium are only beginning to be elucidated. Valvuloseptal tissues arise from endocardial cells Author contributions: M. Nemer designed research; M. Nadeau, R.O.G., A.Y., and J.B. that undergo an epithelial mesenchymal transformation; this performed research; M. Nadeau, R.O.G., B.L., C.L., P.P., B.G.B., and G.A. contributed process is regulated by myocardial-derived growth factors such as new reagents/analytic tools; M. Nadeau, R.O.G., A.Y., P.P., G.A., and M. Nemer analyzed data; and M. Nadeau, R.O.G., and M. Nemer wrote the paper. bone morphogenetic proteins (BMP-2/-4) and VEGF (8, 9). fl Because genes linked to septal defects (in human or animal The authors declare no con ict of interest. models of disease) are either expressed predominantly in myo- *This Direct Submission article had a prearranged editor. cardial cells or are coexpressed in myocytes and endocardial Freely available online through the PNAS open access option. cells, the cellular basis of septal defects remains undefined. 1M. Nadeau and R.O.G. contributed equally to this work. The molecular pathways underlying endocardial development 2Present address: Lady Davis Institute for Medical Research, McGill University, Montreal, remain incompletely understood (10–13). A recent report iden- QC, Canada H3T 1E2. tifies the Ets-related protein-71 as obligatory for endothelial/ 3To whom correspondence should be addressed. E-mail: [email protected]. fi endocardial speci cation (14). Consistent with this, FoxC and This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. Ets transcription factors are sufficient to induce ectopic endo- 1073/pnas.0914888107/-/DCSupplemental. 19356–19361 | PNAS | November 9, 2010 | vol. 107 | no. 45 www.pnas.org/cgi/doi/10.1073/pnas.0914888107 Downloaded by guest on October 1, 2021 12.5. In contrast to GATA4, whose expression marked all cells of frequency of ASD was 3% (one of 40) in control and Tie2Cre- the endocardial cushion, TBX5 localized in only a subset of EC Tbx5wt/wt mice. Direct measurements of chamber mass con- firmed right heart enlargement with increased weight of the right cells (Fig. S1). To assess the role of Tbx5 in endocardial cells, mice − − with endocardium-specific deletion of Tbx5 were generated by atrium and ventricle in eTbx5 / mice, whereas no change was breeding Tbx5 flox mice (28, 29) with Tie2-cre transgenic mice found in the left atrium and ventricle (Fig. 2B). Mice lacking (30). This breeding removes Tbx5 alleles from all endothelial cells, Tbx5 in the endocardium were compared with mice lacking one Tbx5 allele in all cell types produced by crossing with CMV-Cre but because Tbx5 is not expressed in vascular endothelium, the loss − transgenic mice. Tbx5+/ mice (n = 20) showed an intermediary of Tbx5 function is restricted to the endocardium. Genotyping of +/− −/− resulting offspring showed that all the expected genotypes were phenotype between eTbx5 and eTbx5 . Consistent with present in a Mendelian ratio, indicating that removal of Tbx5 from previously published work (28), they displayed right atrial hy- endocardial cells is not embryonic-lethal. This contrasts with the pertrophy, ASD, and larger hearts (Fig. 1B, Right). Histologic embryonic lethality of Tbx5 null mice (28). Immunohistochemistry analysis (Fig. 2A) revealed ASDs and thinning of the valvula of tissue sections confirmed loss of TBX5 from EC but not myo- foramen ovalis (VFO). These results suggest that myocardial cardial cells (Fig. 1A). Tbx5 also contributes to proper formation of the atrial septum. As heterozygote Tbx5 mice have conduction defects (28), Anatomical examination of adult mice with homozygous de- −/− − − electrophysiology of eTbx5 mice was assessed using both letion
Recommended publications
  • Contribution of Enhancer-Driven and Master-Regulator Genes to Autoimmune Disease Revealed Using Functionally Informed SNP-To-Gene Linking Strategies Kushal K
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.02.279059; this version posted March 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Contribution of enhancer-driven and master-regulator genes to autoimmune disease revealed using functionally informed SNP-to-gene linking strategies Kushal K. Dey1, Steven Gazal1, Bryce van de Geijn 1,3, Samuel Sungil Kim 1,4, Joseph Nasser5, Jesse M. Engreitz5, Alkes L. Price 1,2,5 1 Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA 2 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 3 Genentech, South San Francisco, CA 4 Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 5 Broad Institute of MIT and Harvard, Cambridge, MA, USA Abstract Gene regulation is known to play a fundamental role in human disease, but mechanisms of regulation vary greatly across genes. Here, we explore the con- tributions to disease of two types of genes: genes whose regulation is driven by enhancer regions as opposed to promoter regions (Enhancer-driven) and genes that regulate many other genes in trans (Master-regulator). We link these genes to SNPs using a comprehensive set of SNP-to-gene (S2G) strategies and apply stratified LD score regression to the resulting SNP annotations to draw three main conclusions about 11 autoimmune diseases and blood cell traits (average Ncase=13K across 6 autoimmune diseases, average N=443K across 5 blood cell traits).
    [Show full text]
  • Genome-Wide DNA Methylation Analysis of KRAS Mutant Cell Lines Ben Yi Tew1,5, Joel K
    www.nature.com/scientificreports OPEN Genome-wide DNA methylation analysis of KRAS mutant cell lines Ben Yi Tew1,5, Joel K. Durand2,5, Kirsten L. Bryant2, Tikvah K. Hayes2, Sen Peng3, Nhan L. Tran4, Gerald C. Gooden1, David N. Buckley1, Channing J. Der2, Albert S. Baldwin2 ✉ & Bodour Salhia1 ✉ Oncogenic RAS mutations are associated with DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochastic in nature, while other groups propose distinct signaling pathways responsible for aberrant methylation. Better understanding of DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches. Here we analyzed the basal CpG methylation of 11 KRAS-mutant and dependent pancreatic cancer cell lines and observed strikingly similar methylation patterns. KRAS knockdown resulted in unique methylation changes with limited overlap between each cell line. In KRAS-mutant Pa16C pancreatic cancer cells, while KRAS knockdown resulted in over 8,000 diferentially methylated (DM) CpGs, treatment with the ERK1/2-selective inhibitor SCH772984 showed less than 40 DM CpGs, suggesting that ERK is not a broadly active driver of KRAS-associated DNA methylation. KRAS G12V overexpression in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls. In lung and pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in diferentiation and development. Taken all together, KRAS-mediated DNA methylation are stochastic and independent of canonical downstream efector signaling. These epigenetically altered genes associated with KRAS expression could represent potential therapeutic targets in KRAS-driven cancer. Activating KRAS mutations can be found in nearly 25 percent of all cancers1.
    [Show full text]
  • Accompanies CD8 T Cell Effector Function Global DNA Methylation
    Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M.
    [Show full text]
  • Negative Regulators of Colonic Peripheral Regulatory T Cell Development Teresa Lei Ai Washington University in St
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2018 Negative Regulators of Colonic Peripheral Regulatory T Cell Development Teresa Lei Ai Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Ai, Teresa Lei, "Negative Regulators of Colonic Peripheral Regulatory T Cell Development" (2018). Arts & Sciences Electronic Theses and Dissertations. 1509. https://openscholarship.wustl.edu/art_sci_etds/1509 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Immunology Dissertation Examination Committee: Chyi-Song Hsieh, Chair Paul M. Allen Kenneth M. Murphy Gwendalyn J. Randolph Wayne M. Yokoyama Negative Regulators of Colonic Peripheral Regulatory T Cell Development By Teresa Lei Ai A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2018 St. Louis, Missouri
    [Show full text]
  • Evolutionarily Conserved Tbx5–Wnt2/2B Pathway Orchestrates Cardiopulmonary Development
    Evolutionarily conserved Tbx5–Wnt2/2b pathway orchestrates cardiopulmonary development Jeffrey D. Steimlea,b,c, Scott A. Rankind,e,f,g, Christopher E. Slagleh,i,j,k, Jenna Bekenya,b,c, Ariel B. Rydeena,b,c, Sunny Sun-Kin Chanl,m, Junghun Kweona,b,c, Xinan H. Yanga,b,c, Kohta Ikegamia,b,c, Rangarajan D. Nadadura,b,c, Megan Rowtona,b,c, Andrew D. Hoffmanna,b,c, Sonja Lazarevica,b,c, William Thomasn,o, Erin A. T. Boyle Andersonp, Marko E. Horbn,o, Luis Luna-Zuritaq,r, Robert K. Hom, Michael Kybal,m, Bjarke Jensens, Aaron M. Zornd,e,f,g, Frank L. Conlonh,i,j,k, and Ivan P. Moskowitza,b,c,1 aDepartment of Pediatrics, University of Chicago, Chicago, IL 60637; bDepartment of Pathology, University of Chicago, Chicago, IL 60637; cDepartment of Human Genetics, University of Chicago, Chicago, IL 60637; dCenter for Stem Cell and Organoid Medicine, Cincinnati Children’s Research Foundation, Cincinnati, OH 45229; eDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; fDivision of Developmental Biology, Perinatal Institute, Cincinnati Children’s Research Foundation, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229; gDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; hDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; iDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; jIntegrative Program for Biological and Genome Sciences, University of North
    [Show full text]
  • The Role of Tbx5 in Sinoatrial Node Differentiation in Mouse Embryonic Stem Cell Derived Cardiomyocytes Yunkai Dai Clemson University, [email protected]
    Clemson University TigerPrints All Dissertations Dissertations May 2019 The Role of Tbx5 in Sinoatrial Node Differentiation in Mouse Embryonic Stem Cell Derived Cardiomyocytes Yunkai Dai Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Recommended Citation Dai, Yunkai, "The Role of Tbx5 in Sinoatrial Node Differentiation in Mouse Embryonic Stem Cell Derived Cardiomyocytes" (2019). All Dissertations. 2377. https://tigerprints.clemson.edu/all_dissertations/2377 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. THE ROLE OF TBX5 IN SINOATRIAL NODE DIFFERENTIATION IN MOUSE EMBRYONIC STEM CELL DERIVED CARDIOMYOCYTES A Dissertation Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Bioengineering by Yunkai Dai May 2019 Accepted by: Dr Ann Foley, Committee Chair Dr Agneta Simionescu Dr Robin C. Muise-Helmericks Dr Ying Mei ABSTRACT The sinoatrial node of the mouse embryo arises from the wall of the right atrium near the border of the sinus venosus. Early in development this region expresses the transcription factor Tbx5. Because of this, Tbx5 is thought to sit at the apex of a transcriptional cascade leading to sinoatrial node (SAN) differentiation. To test this we produced a mouse embryonic stem cell line B1 (pTripZ-mTbx5; αMHC::GFP) that conditionally overexpresses Tbx5, to determine if this would lead to enhanced SAN differentiation. We found that ES cells overexpressing Tbx5 showed enhanced overall cardiac differentiation and that cardiac cells showed increased beat rates as compared control embryos.
    [Show full text]
  • In Situ Detection of Tbx5 Expression in Developing Chick Embryonic Heart
    San Jose State University SJSU ScholarWorks Master's Theses Master's Theses and Graduate Research Fall 2010 In Situ Detection Of Tbx5 Expression In Developing Chick Embryonic Heart Vaishali Agarwal San Jose State University Follow this and additional works at: https://scholarworks.sjsu.edu/etd_theses Recommended Citation Agarwal, Vaishali, "In Situ Detection Of Tbx5 Expression In Developing Chick Embryonic Heart" (2010). Master's Theses. 3901. DOI: https://doi.org/10.31979/etd.84mn-c4vy https://scholarworks.sjsu.edu/etd_theses/3901 This Thesis is brought to you for free and open access by the Master's Theses and Graduate Research at SJSU ScholarWorks. It has been accepted for inclusion in Master's Theses by an authorized administrator of SJSU ScholarWorks. For more information, please contact [email protected]. IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART A Thesis Presented to The Faculty of the Department of Biological Sciences San Jose State University In Partial Fulfillment of the Requirements for the Degree Master of Science by Vaishali Agarwal December 2010 © 2010 Vaishali Agarwal ALL RIGHTS RESERVED The Designated Thesis Committee Approves the Thesis Titled IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART by Vaishali Agarwal APPROVED FOR THE DEPARTMENT OF BIOLOGICAL SCIENCES SAN JOSE STATE UNIVERSITY December 2010 Dr. Steven White Department of Biological Sciences Dr. Michael Sneary Department of Biological Sciences Dr. Bob Fowler Department of Biological Sciences ABSTRACT IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART by Vaishali Agarwal The Tbx 5 gene codes for a highly conserved transcription factor containing a DNA-binding motif called the T box (or T-domain).
    [Show full text]
  • TBX5 Drives Scn5a Expression to Regulate Cardiac Conduction System Function
    TBX5 drives Scn5a expression to regulate cardiac conduction system function David E. Arnolds, … , Vickas V. Patel, Ivan P. Moskowitz J Clin Invest. 2012;122(7):2509-2518. https://doi.org/10.1172/JCI62617. Research Article Cardiac conduction system (CCS) disease, which results in disrupted conduction and impaired cardiac rhythm, is common with significant morbidity and mortality. Current treatment options are limited, and rational efforts to develop cell- based and regenerative therapies require knowledge of the molecular networks that establish and maintain CCS function. Recent genome-wide association studies (GWAS) have identified numerous loci associated with adult human CCS function, including TBX5 and SCN5A. We hypothesized that TBX5, a critical developmental transcription factor, regulates transcriptional networks required for mature CCS function. We found that deletion of Tbx5 from the mature murine ventricular conduction system (VCS), including the AV bundle and bundle branches, resulted in severe VCS functional consequences, including loss of fast conduction, arrhythmias, and sudden death. Ventricular contractile function and the VCS fate map remained unchanged in VCS-specific Tbx5 knockouts. However, key mediators of fast conduction, including Nav1.5, which is encoded by Scn5a, and connexin 40 (Cx40), demonstrated Tbx5-dependent expression in the VCS. We identified a TBX5-responsive enhancer downstream of Scn5a sufficient to drive VCS expression in vivo, dependent on canonical T-box binding sites. Our results establish a direct molecular link between Tbx5 and Scn5a and elucidate a hierarchy between human GWAS loci that affects function of the mature VCS, establishing a paradigm for understanding the molecular pathology of CCS disease. Find the latest version: https://jci.me/62617/pdf Research article TBX5 drives Scn5a expression to regulate cardiac conduction system function David E.
    [Show full text]
  • Epigenetic Inactivation of T-Box Transcription Factor 5, a Novel Tumor Suppressor Gene, Is Associated with Colon Cancer
    Oncogene (2010) 29, 6464–6474 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 www.nature.com/onc ORIGINAL ARTICLE Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer JYu1,2,XMa1,2,3,7, KF Cheung1,2,XLi1,2, L Tian4, S Wang1,2,CWWu1,2, WKK Wu1,2,MHe5, M Wang3, SSM Ng6 and JJY Sung1,2 1Department of Medicine and Therapeutics, Institute of Digestive Disease, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR China; 2Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, SAR China; 3Department of Neurology, First Hospital, Hebei Medical University, Shijiazhuang, SAR China; 4School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, SAR China; 5Stanley Ho Center for Emerging Infectious Diseases, School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, SAR China and 6Department of Surgery, The Chinese University of Hong Kong, Hong Kong, SAR China T-box transcription factor 5 (TBX5) is a member of a overall survival (P ¼ 0.0007). In conclusion, we identified phylogenetically conserved family of genes involved in the a novel functional tumor suppressor gene TBX5 inacti- regulation of developmental processes. The function of vated by promoter methylation in colon cancer. Detection TBX5 in cancer development is largely unclear. We of methylated TBX5 may serve as a potential biomarker identified that TBX5 was preferentially methylated in for the prognosis of this malignancy. cancer using methylation-sensitive arbitrarily primed Oncogene (2010) 29, 6464–6474; doi:10.1038/onc.2010.370; PCR.
    [Show full text]
  • Transcription Factors Recognize DNA Shape Without Nucleotide Recognition
    bioRxiv preprint doi: https://doi.org/10.1101/143677; this version posted May 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Transcription+factors+recognize+DNA+shape+without+nucleotide+recognition++ Md.$Abul$Hassan$Samee1,$Benoit$G.$Bruneau1,2,$Katherine$S.$Pollard$1,3$ 1:$Gladstone$Institutes,$1650$Owens$St.,$San$Francisco,$CA$94158$ 2:$$Department$of$Pediatrics$and$Cardiovascular$Research$Institute,$University$of$California,$ San$Francisco,$CA$94158$ 3:$Division$of$Bioinformatics,$Institute$for$Human$Genetics,$and$Institute$for$Computational$ Health$Sciences,$University$of$California,$San$Francisco,$CA$94158$ $ + bioRxiv preprint doi: https://doi.org/10.1101/143677; this version posted May 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract+ We$hypothesized$that$transcription$factors$(TFs)$recognize$DNA$shape$without$nucleotide$ sequence$recognition.$Motivating$an$independent$role$for$shape,$many$TF$binding$sites$lack$ a$sequenceZmotif,$DNA$shape$adds$specificity$to$sequenceZmotifs,$and$different$sequences$ can$ encode$ similar$ shapes.$ We$ therefore$ asked$ if$ binding$ sites$ of$ a$ TF$ are$ enriched$ for$ specific$patterns$of$DNA$shapeZfeatures,$e.g.,$helical$twist.$We$developed$ShapeMF,$which$ discovers$ these$ shapeZmotifs$ de%novo%without$ taking$ sequence$ information$ into$ account.$
    [Show full text]
  • Mechanisms Underlying Differential Response to Estrogen-Induced Apoptosis in Long-Term Estrogen-Deprived Breast Cancer Cells
    INTERNATIONAL JOURNAL OF ONCOLOGY 44: 1529-1538, 2014 Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells ELIZABETH E. SWEENEY, PING FAN and V. CRAIG JORDAN Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA Received December 12, 2013; Accepted December 30, 2013 DOI: 10.3892/ijo.2014.2329 Abstract. Models of long-term estrogen-deprived breast receptor (ER)-positive cell line MCF-7 that is highly sensitive cancer cells are utilized in the laboratory to mimic clinical to E2-stimulated growth (1). The MCF-7:5C and MCF-7:2A aromatase inhibitor-resistant breast cancer and serve as a subclones are derived from the parental MCF-7 cell line tool to discover new therapeutic strategies. The MCF-7:5C through long-term E2 deprivation (1-4). MCF-7:5C cells and MCF-7:2A subclones were generated through long-term express wild-type ER at a higher level than the parental line, estrogen deprivation of estrogen receptor (ER)-positive MCF-7 and are progesterone receptor (PR)-negative (3). These cells cells, and represent anti-hormone-resistant breast cancer. grow in the absence of E2, and do not respond to 4-hydroxy- MCF-7:5C cells paradoxically undergo estrogen-induced tamoxifen (4-OHT) (2,3). MCF-7:2A cells can induce apoptosis within seven days of estrogen (estradiol, E2) treat- expression of PR and express both wild-type (66 kDa) and ment; MCF-7:2A cells also experience E2-induced apoptosis mutant (77 kDa) ER (4,5). The mutant ER contains a repeat but evade dramatic cell death until approximately 14 days of of exons 6 and 7 and cannot bind E2 nor anti-estrogens; it is treatment.
    [Show full text]
  • Life-Threatening Cardiac Episode in a Polish Patient Carrying Contiguous Gene Microdeletion of the TBX5 and the TBX3 Genes
    Iwanicka‑Pronicka et al. SpringerPlus (2016) 5:1638 DOI 10.1186/s40064-016-3275-1 CASE STUDY Open Access Life‑threatening cardiac episode in a Polish patient carrying contiguous gene microdeletion of the TBX5 and the TBX3 genes Katarzyna Iwanicka‑Pronicka1,2*, Magdalena Socha3, Maria Jędrzejowska1, Małgorzata Krajewska‑Walasek1 and Aleksander Jamsheer3,4 Abstract Holt–Oram syndrome (HOS) features radial ray hypoplasia, heart defect and cardiac conduction impairment. Ulnar- mammary syndrome (UMS) characterizes congenital defects of the ulnar side of the upper limbs, underdevelop‑ ment of apocrine glands including hypoplasia and the dysfunction of mammary glands, hypogonadism and obesity. Inheritance of both conditions is autosomal dominant, mutations or deletions are found in the TBX5 and TBX3 gene, respectively. The Polish patient presented short stature, obesity, congenital malformation of the radial and ulnar side of the upper limbs, heart block, hypogonadism and dysmorphic features. At the age of 13 years he lost conscious‑ ness developing respiratory insufficiency caused by bradycardia in the course of sudden atrioventricular third degree heart block requiring immediate implantation of pace maker-defibrillator device. Microdeletion of the 12q24.21 was identified using array CGH method. This region includes contiguous genes the TBX5, TBX3, and part of RBM19. The patient initially diagnosed as having HOS, was found to present the UMS features as well. Array CGH method should be applied in patients suspected of HOS or UMS, especially
    [Show full text]